Comedy vs Cancer Sells Out Jazz at Lincoln Center
09 Mayo 2024 - 11:28AM
Comedy vs Cancer, Memorial Sloan Kettering Cancer Center’s (MSK)
official comedy benefit show for blood cancer research, raised over
$1.3 million on Tuesday, May 7. Over 1,000 supporters attended the
one-night-only event at Jazz at Lincoln Center’s Frederick P. Rose
Hall in New York City.
Hosted by Nick Kroll, Comedy vs Cancer featured
performances by Tina Fey, John Oliver, Jim Gaffigan, Alex
Edelman, and the cast of Netflix’s
Girls5eva, which includes
Sara Bareilles, Busy
Philipps, Renée Elise Goldsberry, and Paula Pell. “There's
no better way to fight blood cancer than by funding the incredible
work of experts at MSK,” said Kroll. Attendees included
Steve Martin, Jon
Hamm, and Ellie Kemper.
Comedy vs Cancer and MSK are dedicated to improving outcomes for
people with blood cancer, including those with acute myeloid
leukemia (AML), which is caused by the uncontrolled growth of
abnormal immature blood cells in the bone marrow.
The FDA recently approved a phase 1 clinical trial for an
investigational immunotherapy developed by a team of MSK
hematologist-oncologists, including Anthony Daniyan, MD; Mark
Geyer, MD; and Kevin J. Curran, MD. The potential new treatment is
designed to seek and destroy acute myeloid leukemia cancer cells
that survive after chemotherapy.
“Without funding from Comedy vs Cancer, we wouldn’t be where we
are today — advancing immunotherapy for blood cancers,” said Dr.
Curran, the Pediatric Director of the Cellular Therapeutic Center
at MSK.
Comedy vs Cancer was founded by Niccole and Jeremy Kroll,
Jennifer Rogers and Robert Carlock, and Nick Kroll and Lily Kwong.
This year’s show was made possible by corporate support from
Netflix, Kreindler & Kreindler, Esquire Bank and the leadership
of the Host Committee, which is a group of volunteers committed to
advancing MSK’s mission of ending cancer for life.
Since 2019, Comedy vs Cancer has directed more than $4 million
into MSK labs, where doctors and researchers are working every day
to unlock new cures for people with blood cancer in New York City
and worldwide.
MORE INFORMATION
About Memorial Sloan Kettering Cancer
CenterThe people of Memorial Sloan Kettering Cancer Center
(MSK) are united by a singular mission: ending cancer for life. Our
specialized care teams provide personalized, compassionate, expert
care to patients of all ages. Informed by basic research done at
our Sloan Kettering Institute, scientists across MSK collaborate to
conduct innovative translational and clinical research that is
driving a revolution in our understanding of cancer as a disease
and improving the ability to prevent, diagnose, and treat it. MSK
is dedicated to training the next generation of scientists and
clinicians, who go on to pursue our mission at MSK and around the
globe. One of the world’s most respected comprehensive centers
devoted exclusively to cancer, we have been recognized as one of
the top two cancer hospitals in the country by U.S. News &
World Report for more than 30 years. www.mskcc.org
CONTACT:Maggie
Hopfhopfm@mskcc.org646-988-4355